| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.07B | $2.15B | $2.16B |
| YoY Revenue Growth % | -4.0% | 0.0% | — |
| Gross Profit | $1.04B | $1.11B | — |
| Gross Margin % | 50.3% | 51.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.18B | $459.6M | $511.8M |
| Operating Margin % | -57.2% | 21.3% | 23.7% |
| Net Income (GAAP) | -$1.22B | $354.6M | $416.8M |
| EBITDA (Normalized) | -$1.15B | $487.0M | $589.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $397.6M | $454.5M | $461.8M |
| Capital Expenditures (CapEx) | $39.2M | $34.3M | $97.0M |
| Free Cash Flow (FCF) | $358.4M | $420.2M | $364.8M |
| FCF Margin % | 17.3% | 19.5% | 16.9% |
| Return on Invested Capital (ROIC %) | -45.0% | 9.6% | 15.6% |
| Cash & Short-Term Equivalents | $318.8M | $0 | — |
| Total Debt (Short + Long Term) | $618.4M | $0 | $1.00B |
| Total Stockholders' Equity | $1.63B | $3.76B | $2.06B |